Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Superior PFS2 with VTD Vs TD for Newly Diagnosed, Transplant Eligible, Multiple Myeloma (MM) Patients: Updated Analysis of Gimema MMY-3006 Study

Paola Tacchetti, MD, Lucia Pantani, MD, Valerio De Stefano, MD, Elena Zamagni, MD, Jacopo Peccatori, MD, Annalisa Pezzi, Statistician, Catello Califano, MD, Andrea Nozza, MD, Patrizia Tosi, MD, Carolina Terragna, PhD, Fabrizio Ciambelli, MD, Delia Cangini, MD, Piero Galieni, MD, Clotilde Cangialosi, MD, Giovanni De Sabbata, MD, Francesca Elice, MD, Antonio Palumbo, MD, Michele Cavo, MD

Blood (2014) 124 (21): 196.

https://doi.org/10.1182/blood.V124.21.196.196

Published: 2014

Journal Articles

Patologic IL 17 Producing Helper T Cells In Acute Myeloid Leukemia Patients

Gerardo Musuraca, MD, PhD, Serena De Matteis, Roberta Napolitano, Francesco Fabbri, Delia Cangini, MD, Michela Ceccolini, MD, Maria Benedetta Giannini, MD, Alessandro Lucchesi, MD, Sonia Ronconi, MD, Cristina Papayannidis, MD, Viviana Guadagnuolo, Giovanni Martinelli, MD, Paolo Savini, MD, Monica Tani, MD, Patrizia Tosi, MD, Dino Amadori, MD, Pier Paolo Fattori, MD, Wainer Zoli, Silvia Carloni

Blood (2013) 122 (21): 2289.

https://doi.org/10.1182/blood.V122.21.2289.2289

Published: 2013

Journal Articles

Superior Complete Remission/Very Good Partial Remission Rate with Peri-Transplant Administration of Thalidomide-Dexamethasone for Newly Diagnosed Multiple Myeloma.

Michele Cavo, MD, Elena Zamagni, MD, Patrizia Tosi, MD, Delia Cangini, MD, Paola Tacchetti, MD, Claudia Cellini, MD, Nicoletta Testoni, PhD, Chiara Nicci, PhD, Antonio de Vivo, MD, Giulia Perrone, MD, Michela Ceccolini, MD, Michele Baccarani, MD

Blood (2005) 106 (11): 5474.

https://doi.org/10.1182/blood.V106.11.5474.5474

Published: 2005

Journal Articles

Bisphosphonates and Osteonecrosis of the Jaws: Incidence in a Homogeneous Series of Patients with Newly Diagnosed Multiple Myeloma Treated with Zoledronic Acid.

Patrizia Tosi, MD, Elena Zamagni, MD, Delia Cangini, MD, Paola Tacchetti, MD, Massimo Offidani, MD, Sonia Ronconi, MD, Giulia Perrone, MD, Michela Ceccolini, MD, Michele Baccarani, MD, Sante Tura, MD, Michele Cavo, MD

Blood (2005) 106 (11): 3461.

https://doi.org/10.1182/blood.V106.11.3461.3461

Published: 2005

Journal Articles

Thalidomide-Induced Peropheral Neuropathy in Newly Diagnosed and Pre-Treated Multiple Myeloma Patients.

Patrizia Tosi, MD, Elena Zamagni, MD, Claudia Cellini, MD, Delia Cangini, MD, Paola Tacchetti, MD, Giulia Perrone, MD, Sante Tura, MD, Michele Baccarani, MD, Michele Cavo, MD

Blood (2004) 104 (11): 4898.

https://doi.org/10.1182/blood.V104.11.4898.4898

Published: 2004

NARROW

Superior PFS2 with VTD Vs TD for Newly Diagnosed, Transplant Eligible, Multiple Myeloma (MM) Patients: Updated Analysis of Gimema MMY-3006 Study

Patologic IL 17 Producing Helper T Cells In Acute Myeloid Leukemia Patients

Superior Complete Remission/Very Good Partial Remission Rate with Peri-Transplant Administration of Thalidomide-Dexamethasone for Newly Diagnosed Multiple Myeloma.

Bisphosphonates and Osteonecrosis of the Jaws: Incidence in a Homogeneous Series of Patients with Newly Diagnosed Multiple Myeloma Treated with Zoledronic Acid.

Thalidomide-Induced Peropheral Neuropathy in Newly Diagnosed and Pre-Treated Multiple Myeloma Patients.

Email alerts

ASH Publications

American Society of Hematology

Superior PFS2 with VTD Vs TD for Newly Diagnosed, Transplant Eligible, Multiple Myeloma (MM) Patients: Updated Analysis of Gimema MMY-3006 Study

Patologic IL 17 Producing Helper T Cells In Acute Myeloid Leukemia Patients

Superior Complete Remission/Very Good Partial Remission Rate with Peri-Transplant Administration of Thalidomide-Dexamethasone for Newly Diagnosed Multiple Myeloma.

Bisphosphonates and Osteonecrosis of the Jaws: Incidence in a Homogeneous Series of Patients with Newly Diagnosed Multiple Myeloma Treated with Zoledronic Acid.

Thalidomide-Induced Peropheral Neuropathy in Newly Diagnosed and Pre-Treated Multiple Myeloma Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only